Biotech Companys Newsor recently announced a pig pig in a second person patient. These animals-to-man organic transplant, or xenotransplant, are done by editing and cloning progresses.

With insufficient kidneys to meet the need for transplants, egenesis and other companies trying to help catch the help of the help of Crispro Cas9A gene editing technology won the 2020 Nobel Prize in Chemistry.

By editing the pig genome to remove the pork dna targets and enter specific human sequences, epenesis can reduce the risk of organ infection and cross-species infection.

“Some people have the wrong sense that we edit mature animals. We don’t. We have edited the cells from the cells of the cells and CEO Mike Curtis.

Donor animals are raised in a more controlled environment to reduce the risk of any pathogens that lead to the facility.

Curtis told me that Egenesis plans a lot of extra transitions this year, with the intention to end with a test of about 50 patients with enough data to use this method.

As for Xenotranpanplant in Tim Andrews, he is his new kidney for about two months, and the most recent word from Egenesis is that he is good.

For more of our scope of egenesis and xenotransplants, check out the video of this article.